JUN 23, 2017 8:23 PM PDT

Delivering A New HIV Vaccine

WRITTEN BY: Kara Marker

Creating a successful vaccine for HIV has so far been unsuccessful, but now scientists are zeroing in on two important factors for perfecting the vaccine: timing and mode of delivery.

The vaccine candidates used in the study mimic the trimeric envelope protein spikes on the surface of HIV. Rendering of HIV with envelope protein trimers clearly visible on the virus surface. Credit: La Jolla Institute for Allergy and Immunology

The potential HIV vaccine is based on neutralizing antibodies, which attach to viruses and prevent them from promoting infection. However, in the past neutralizing antibodies have been “notoriously difficult” to create in the context of targeting HIV. From the La Jolla Institute for Allergy and Immunology, researchers tested the efficacy of an optimized vaccine in non-human primates, a traditional model for studying HIV. However, the initial vaccine wasn’t successful at first.

"The animals' immune responses, although the right kind, weren't very robust and a few didn't respond at all," explained Colin Havenar-Daughton, PhD. "That caused significant concern that the immunogen wouldn't consistently trigger an effective immune response in all individuals in a human clinical trial."

They improved upon the vaccine, using subcutaneous delivery - under the skin like insulin and morphine injections. Additionally, they increased the time intervals between immunizations, ensuring a slow and steady delivery. This makes the vaccine’s effect stronger, activating the neutralizing antibodies.

"Depending on how we gave the vaccine, there was a bigger difference due to immunization route than we would have predicted," explained co-lead author Matthias Pauthner. "We can help translate what we know now into the clinic."

HIV in 2017

HIV is now relatively considered to be a “chronic, manageable disease” thanks to antiretroviral drugs that treat AIDS. Although, accessibility to these drugs isn’t guaranteed; only half of people living with HIV have access to treatment, and new people are contracting the disease every day. The new

"The vaccine candidates we worked with here are probably the most promising prototypes out there, and one will go into people in 2018," said Professor Dennis R. Burton, PhD.

The present study was published in the journal Immunity.

 

Source: La Jolla Institute for Allergy and Immunology, Healthline

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 09, 2021
Cancer
Can a Mole Fight Melanoma?
SEP 09, 2021
Can a Mole Fight Melanoma?
About 30% of melanoma cases arise from an existing nevus.  More commonly known as moles, Nevi are skin growths that ...
OCT 14, 2021
Genetics & Genomics
RSV Infections Can Modify Host Immune Gene Activity
OCT 14, 2021
RSV Infections Can Modify Host Immune Gene Activity
Respiratory syncytial virus (RSV) are thought to be incredibly common; research has suggested that almost everyone is ev ...
OCT 18, 2021
Genetics & Genomics
A Decade After Gene Therapy, SCID Patients Are Doing Well
OCT 18, 2021
A Decade After Gene Therapy, SCID Patients Are Doing Well
For decades, scientists have been trying to find ways to cure disorders that can be traced back to an error in one gene. ...
NOV 16, 2021
Immunology
How a BBQ Lighter Inspired a New Vaccine Technology
NOV 16, 2021
How a BBQ Lighter Inspired a New Vaccine Technology
It’s the size of a pen, weighs as much as two AA batteries, and works without a power source. A new microneedle de ...
NOV 17, 2021
Health & Medicine
Nutrients for Reducing Autoimmune Disease Risk
NOV 17, 2021
Nutrients for Reducing Autoimmune Disease Risk
Want to reduce your chances of having your immune system turn on your body and start destroying your perfect health? Loo ...
DEC 02, 2021
Cancer
A New Method to Enhance Immunotherapy in Mouse Tumors
DEC 02, 2021
A New Method to Enhance Immunotherapy in Mouse Tumors
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer, accounting for about 90% of pancre ...
Loading Comments...